Intercure

INCRNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$62.131 M

$5.25 -1.22%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

54,681,335

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#339Boundless BioBOLD$64.4M
#340Zhengye BiotechnologyZYBT$64.0M
#341IntercureINCR$62.1M
#342PDS BiotechnologyPDSB$61.0M
#343TalpheraTLPH$60.7M

What if Intercure were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,555,698

Per share 487,264× higher

Bitcoin $1.72T

$145,183.66

Per share 27,680× higher

Nvidia $5.48T

$462,602.71

Per share 88,199× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Intercure are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.